glp-1 advertising crackdown news GLP-1 ad battle: Ozempic and Wegovy maker on the Hims & Hers Super Bowl ad FDA to Restrict Ingredients Used

While prescriptions for weight loss medication cannot be guaranteed for every patient, if you are 18 years of age or older and meet specific criteria such as weight and certain associated health conditions, your healthcare provider may consider you eligible for a prescription

MounjaroTM (tirzepatide) injection, for subcutaneous use: US prescribing information (2022)

Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-controlled trial design

Ozempic isnt FDA-approved for PMOS, but some providers prescribe it off-label for potential benefits